参考文献/References:
[1]GOLLAPALLI K, RAY S, SRIVASTAVA R, et al. Investigation of serum proteome alterations in human glioblastoma multiforme [J]. Proteomics, 2012, 12(14): 2378-2390.
[2]KUMAR DM, THOTA B, SHINDE SV, et al. Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth [J]. J Proteome Res, 2010, 9(11): 5557-5567.
[3]VAN LINDE ME, VAN DER MIJN JC, PHAM TV, et al. Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma [J]. J Neurooncol, 2016, 129(2): 221-230.
[4]QIN G, LI X, CHEN Z, et al. Prognostic value of YKL-40 in patients with glioblastoma: a systematic review and meta-analysis [J]. Mol Neurobiol, 2017, 54(5): 3264-3270.
[5]GáLLEGO PéREZ-LARRAYA J, PARIS S, IDBAIH A, et al. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma [J]. Cancer, 2014, 120(24): 3972-3980.
[6]NIGRO JM, MISRA A, ZHANG L, et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma [J]. Cancer Res, 2005, 65(5): 1678-1686.
[7]MASSAGUé J, OBENAUF AC. Metastatic colonization by circulating tumour cells [J]. Nature, 2016, 529(7586): 298-306.
[8]JONES J, NGUYEN H, DRUMMOND K, et al. Circulating biomarkers for Glioma: A Review [J]. Neurosurgery, 2021, 88(3): E221-E230.
[9]JELSKI W, MROCZKO B. Molecular and circulating bio-markers of brain tumors [J]. Int J Mol Sci, 2021, 22(13): 7039.
[10]ABELS ER, BREAKEFIELD XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake [J]. Cell Mol Neurobiol, 2016, 36(3): 301-312.
[11]ZHONG F, HUANG T, LENG J. Serum miR-29b as a novel biomarker for glioblastoma diagnosis and prognosis [J]. Int J Clin Exp Pathol, 2019, 12(11): 4106-4112.
[12]SHAO N, XUE L, WANG R, et al. miR-454-3p is an exo-somal biomarker and functions as a tumor suppressor in glioma [J]. Mol Cancer Ther, 2019, 18(2): 459-469.
[13]DRUSCO A, FADDA P, NIGITA G, et al. Circulating micrornas predict survival of patients with tumors of glial origin [J]. EBioMedicine, 2018, 30: 105-112.
[14]QUINN JJ, CHANG HY. Unique features of long non-coding RNA biogenesis and function [J]. Nat Rev Genet, 2016, 17(1): 47-62.
[15]LI Y, ZHENG Q, BAO C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis [J]. Cell Res, 2015, 25(8): 981-984.
[16]BONNER ER, BORNHORST M, PACKER RJ, et al. Liquid biopsy for pediatric central nervous system tumors [J]. NPJ Precis Oncol, 2018, 2: 29.
[17]MARTíNEZ-RICARTE F, MAYOR R, MARTíNEZ-SáEZ E, et al. Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cere-brospinal fluid [J]. Clin Cancer Res, 2018, 24(12): 2812-2819.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(08):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(08):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(08):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(08):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(08):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(08):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(08):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(08):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]